Results 121 to 130 of about 4,412 (151)

New-onset systemic lupus erythematosus after BBIBP-CorV vaccination. [PDF]

Clin Case Rep
Pourkarim F, Khani E, Ghadakchi L, Ebrahimian S.   +3 more
europepmc   +1 more source

Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination. [PDF]

Travel Med Infect Dis, 2023
Zhang Y, Guo X, Han S, Yao M, Zhang L, Zhao L, Zhang J, Jiang X, Zhang S, Pang B, Wang J, Wang S, Fang M, Liu X, Kou Z, Jiang X.   +15 more
europepmc   +1 more source

Upper extremity deep vein thrombosis following BBIBP-CorV COVID-19 vaccine (Sinopharm vaccine): A case report. [PDF]

Clin Case Rep, 2023
Riazi A, Faghih Dinevari M, Abbasian S, Jabbaripour Sarmadian A.   +3 more
europepmc   +1 more source

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique. [PDF]

Clin Infect Dis
Ramgi P, Siribie M, Rakotozandrindrainy N, Bule O, Shrivastava H, Chambule L, Park EL, Fernando C, Boque J, Macuiana R, Razafimanantsoa R, Rakotozandrindrainy N, Razafindrabe TJL, Rakotoarisoa AN, Raminosoa TM, Derandrainy HL, Rakotoson MM, de Silva CSS, Mutombene M, Massinga C, Langa JP, Guarnacci T, Kang SSY, Jo SK, Jeon HJ, Excler JL, Yang Y, Wang S, Sugimoto JD, Yang JS, Shim BS, Binger T, Capitine IU, Aziz AB, Park JY, Kim DR, Rakotozandrindrainy R, Jani IV, Tadesse BT, Marks F.   +39 more
europepmc   +1 more source

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing. [PDF]

Emerg Microbes Infect, 2023
Tong R, Luo L, Zhao Y, Sun M, Li R, Zhong J, Chen Y, Hu L, Li Z, Shi J, Lyu Y, Hu L, Guo X, Liu Q, Shuang T, Zhang C, Yuan A, Sun L, Zhang Z, Qian K, Chen L, Lin W, Chen AF, Wang F, Pu J.   +24 more
europepmc   +1 more source

Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study. [PDF]

BMJ Open
De Silva ST, Ediriweera DS, Wimalasena W, Kariyawasam M, Kosinna G, Bogoda G, Senaratne S, Rathnayake K, Weerarathna I, Premaratna R, Gunasena P.   +10 more
europepmc   +1 more source

Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021. [PDF]

Travel Med Infect Dis, 2023
Silva-Valencia J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, Moscoso-Porras M, Solari L, Mayta-Tristán P.   +6 more
europepmc   +1 more source

Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy. [PDF]

BMC Pregnancy Childbirth
Hatami D, Habibelahi A, Changizi N, Heidarzadeh M, Nojomi M, Rast M, Ansari K, Tehrani-Banihashemi A.   +7 more
europepmc   +1 more source

Investigating the impact of prior COVID-19 on IgG antibody and interferon γ responses after BBIBP-CorV vaccination in a disease endemic population: A prospective observational study. [PDF]

Health Sci Rep, 2023
Hasan Z, Masood KI, Qaiser S, Khan E, Hussain A, Ghous Z, Khan U, Yameen M, Hassan I, Nasir MI, Qazi MF, Memon HA, Ali S, Baloch S, Bhutta ZA, Veldhoen M, Pedro Simas J, Mahmood SF, Ghias K, Hussain R.   +19 more
europepmc   +1 more source

Correction: Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco. [PDF]

PLoS One
Belayachi J, Obtel M, Mhayi A, Razine R, Abouqal R.   +4 more
europepmc   +1 more source